Epicrispr Biotechnologies
Developer of gene therapies designed to treat various genetic diseases that currently lack effective treatments. The company focuses on precisely regulating gene activity by turning genes on or off th...
Valuation
$0
Share Price
N/A
Total Raised
$123M
Last Round
N/A